Day: January 16, 2022

Blog article

Biden team regroups after court loss on COVID shots-or-test

Concerned but not giving up, President Joe Biden is anxiously pushing ahead to prod people to get COVID-19 shots after the Supreme Court put a halt to the administration’s sweeping vaccinate-or-test plan for large employers.

At a time when hospitals are being overrun and record numbers of people are getting infected with the omicron variant, the administration hopes states and companies will order their own vaccinate-or-test requirements. And if the presidential “bully pulpit” still counts for persuasion, Biden intends to use it.

While some in the business community cheered the defeat of the mandate, Biden insisted the administration effort has not been for naught. The high court’s ruling on Thursday “does not stop me from using my voice as president to advocate for employers to do the right thing to protect Americans’ health and economy,” he said.

The court’s conservative majority all-but-struck down the Occupational Safety and Health Administration’s requirement

Read More
Health News

Mexico sees fake molnupiravir, 1 week after drug approved

Mexico said Friday it is already seeing black market or fake versions of molnupiravir circulating for sale, just one week after authorities approved the drug to treat those at risk of severe COVID-19.

The real medication is produced by U.S. pharmaceutical company Merck. But Mexico’s health regulatory agency found versions labelled molnupiravir for sale from an array of companies like “Merit,” “Molaz” and “Azista.”

The agency said Friday that it had no record of any permits for import or sales of those companies’ drugs and considered them a health .

The Federal Commission for Health Protection wrote that, because molnupiravir is approved only for prescription use, “any product advertised as over-the-counter molnupiravir should be considered a health risk because of its dubious origin.”

Mexico’s government approved molnupiravir from Merck for use last week for adults with COVID-19 and “a high risk of complications.” On Friday the agency approved a

Read More